Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Sweeney

Showing results (161-170 of 170) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 170 results.
Science Translational Medicine|February 6, 2015
Effect of selective LRRK2 kinase inhibition on nonhuman primate lungReina N Fuji, Michael Flagella, Miriam Baca, et al.
Journal of Medicinal Chemistry|December 21, 2013
Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitorsAnthony A Estrada, Bryan K Chan, Charles Baker-Glenn, et al.
Science Translational Medicine|May 29, 2020
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeysMihalis S Kariolis, Robert C Wells, Jennifer A Getz, et al.
Bioorganic & Medicinal Chemistry|September 19, 2017
Development of a cyclosporin A derivative with excellent anti-hepatitis C virus potencyJiping Fu, Christopher Becker, Li Cao, et al.
Science Translational Medicine|June 8, 2022
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's diseaseDanna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, et al.
Journal of Medicinal Chemistry|September 19, 2012
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitorsAnthony A Estrada, Xingrong Liu, Charles Baker-Glenn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2022
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapyK White, K Connor, M Meylan, et al.
Science Translational Medicine|May 29, 2020
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in miceJulie C Ullman, Annie Arguello, Jennifer A Getz, et al.
Journal of Medicinal Chemistry|May 26, 2012
Discovery of novel PI3-kinase δ specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibitionBrian S Safina, Stewart Baker, Matt Baumgardner, et al.
Science (New York, N.Y.)|August 7, 2025
Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIAMichelle E Pizzo, Edward D Plowey, Nathalie Khoury, et al.
Pageof 17

Showing results (161-170 of 170) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 170 results.
Science Translational Medicine|February 6, 2015
Effect of selective LRRK2 kinase inhibition on nonhuman primate lungReina N Fuji, Michael Flagella, Miriam Baca, et al.
Journal of Medicinal Chemistry|December 21, 2013
Discovery of highly potent, selective, and brain-penetrant aminopyrazole leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitorsAnthony A Estrada, Bryan K Chan, Charles Baker-Glenn, et al.
Science Translational Medicine|May 29, 2020
Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeysMihalis S Kariolis, Robert C Wells, Jennifer A Getz, et al.
Bioorganic & Medicinal Chemistry|September 19, 2017
Development of a cyclosporin A derivative with excellent anti-hepatitis C virus potencyJiping Fu, Christopher Becker, Li Cao, et al.
Science Translational Medicine|June 8, 2022
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson's diseaseDanna Jennings, Sarah Huntwork-Rodriguez, Anastasia G Henry, et al.
Journal of Medicinal Chemistry|September 19, 2012
Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitorsAnthony A Estrada, Xingrong Liu, Charles Baker-Glenn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2022
Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapyK White, K Connor, M Meylan, et al.
Science Translational Medicine|May 29, 2020
Brain delivery and activity of a lysosomal enzyme using a blood-brain barrier transport vehicle in miceJulie C Ullman, Annie Arguello, Jennifer A Getz, et al.
Journal of Medicinal Chemistry|May 26, 2012
Discovery of novel PI3-kinase δ specific inhibitors for the treatment of rheumatoid arthritis: taming CYP3A4 time-dependent inhibitionBrian S Safina, Stewart Baker, Matt Baumgardner, et al.
Science (New York, N.Y.)|August 7, 2025
Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIAMichelle E Pizzo, Edward D Plowey, Nathalie Khoury, et al.
Pageof 17